Results 141 to 150 of about 1,825 (158)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation, 2019
FRANCISCO Marty, Kathleen Mullane, Michael Boeckh   +2 more
exaly  

Effect of the side chain on the properties from cidofovir to brincidofovir, an experimental antiviral drug against to Ebola virus disease

Arabian Journal of Chemistry, 2019
Silvia Brandan, Davide Romani
exaly  

Brincidofovir for Adenovirus Disease in Intestinal Transplant Patients

Transplantation, 2017
Mohamed Safwan, Shunji Nagai, Michael Rizzari, Marwan Aboujoud, Mohammad Raoufi, Nimisha Sulejmani, Mayur Ramesh   +6 more
openaire   +1 more source

Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience

Antiviral Research, 2016
Dimpy P Shāh, , Danielle El Haddad
exaly  

Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series

Pediatric Transplantation, 2020
Jackson Londeree, René Romero, Pamela D Winterberg   +2 more
exaly  

Brincidofovir for Polyomavirus-Associated Nephropathy After Allogeneic Hematopoietic Stem Cell Transplantation

American Journal of Kidney Diseases, 2015
James Young, Ilya Glezerman, Yeon Joo Lee   +2 more
exaly  

Brincidofovir/cidofovir/tacrolimus

Reactions Weekly, 2019
openaire   +1 more source

The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus

Antiviral Research, 2016
Gene Olinger, Christina Spiropoulou, Michael Flint   +2 more
exaly  

Aciclovir/brincidofovir

Reactions Weekly
openaire   +1 more source

Orphan designation: Brincidofovir, treatment of smallpox

Case Medical Research, 2019
openaire   +1 more source